600518 康美药业
已收盘 08-21 15:00:00
资讯
新帖
简况
康美药业:已聘请国内头部券商协助开展市值管理相关工作
证券之星 · 08-06
康美药业:已聘请国内头部券商协助开展市值管理相关工作
康美药业:抵债股票由管理人进行公开处置
证券之星 · 08-06
康美药业:抵债股票由管理人进行公开处置
康美药业:董事及高级管理人员2026年度薪酬由基本薪酬和绩效奖金组成
证券之星 · 08-06
康美药业:董事及高级管理人员2026年度薪酬由基本薪酬和绩效奖金组成
康美药业:公司目前生产经营正常
证券之星 · 08-06
康美药业:公司目前生产经营正常
康美药业:已建立股价动态监测机制
证券之星 · 08-06
康美药业:已建立股价动态监测机制
康美药业:率先进入更高端的中药饮片市场
证券之星 · 08-06
康美药业:率先进入更高端的中药饮片市场
康美药业:中药配方颗粒、趁鲜加工已纳入统一追溯体系
证券之星 · 08-06
康美药业:中药配方颗粒、趁鲜加工已纳入统一追溯体系
康美药业:公司控股股东为广东神农氏企业管理合伙企业(有限合伙)
证券之星 · 08-06
康美药业:公司控股股东为广东神农氏企业管理合伙企业(有限合伙)
康美药业:2025年现金净流入2.23亿元
证券之星 · 08-06
康美药业:2025年现金净流入2.23亿元
康美药业:公司现有溯源平台采用的是企业自定义编码规则
证券之星 · 08-06
康美药业:公司现有溯源平台采用的是企业自定义编码规则
每周股票复盘:康美药业(600518)获139,643.48万元赔偿一审判决
证券之星 · 07-26
每周股票复盘:康美药业(600518)获139,643.48万元赔偿一审判决
康美药业新注册《康美药业中药药事服务代煎代配处方服务全过程信息追溯平台1.0》等2个项目的软件著作权
证券之星 · 07-24
康美药业新注册《康美药业中药药事服务代煎代配处方服务全过程信息追溯平台1.0》等2个项目的软件著作权
赵建2026年二季度表现,国投瑞银上证科创板人工智能指数发起式A基金季度涨幅40.24%
证券之星 · 07-21
赵建2026年二季度表现,国投瑞银上证科创板人工智能指数发起式A基金季度涨幅40.24%
康美药业获得实用新型专利授权:“一种卸液装置及药渣处理设备”
证券之星 · 07-21
康美药业获得实用新型专利授权:“一种卸液装置及药渣处理设备”
康美药业获得实用新型专利授权:“一种接料辅助装置”
证券之星 · 07-04
康美药业获得实用新型专利授权:“一种接料辅助装置”
股市必读:康美药业(600518)6月26日董秘有最新回复
证券之星 · 06-29
股市必读:康美药业(600518)6月26日董秘有最新回复
康美药业:公司生产经营正常,目前没有触及退市风险警示情形
证券之星 · 06-26
康美药业:公司生产经营正常,目前没有触及退市风险警示情形
康美药业:截至2026年3月31日,公司股东总户数为300,298户
证券之星 · 06-26
康美药业:截至2026年3月31日,公司股东总户数为300,298户
康美药业:中药饮片仍是公司的核心主业和战略基石
证券之星 · 05-29
康美药业:中药饮片仍是公司的核心主业和战略基石
每周股票复盘:康美药业(600518)召开2025年年度股东会
证券之星 · 05-17
每周股票复盘:康美药业(600518)召开2025年年度股东会
加载更多
公司概况
公司名称:
康美药业股份有限公司
所属行业:
医药制造业
上市日期:
2001-03-19
主营业务:
康美药业股份有限公司的主营业务是以中药饮片生产、销售为核心,实施中医药全产业链一体化。公司的主要产品是保宁半夏颗粒、乐脉丸、心脑欣丸、清热解毒的抗感解毒颗粒、解毒利咽的板蓝根颗粒、复方板蓝根颗粒,解表散热的小柴胡颗粒、清肝明目的夏桑菊颗粒、滋阴补肾的六味地黄丸、阿咖酚散、新开河超微参粉胶囊、康美菊皇口服液浓缩液、康美怡泰口服液浓缩液、菊皇茶、固体饮料、人参片、红参浸膏。公司是国家技术创新示范企业、国家知识产权示范企业,也是国内唯一的中药饮片智能制造试点示范企业。
发行价格:
12.57
{"stockData":{"symbol":"600518","market":"SH","secType":"STK","nameCN":"康美药业","latestPrice":1.36,"timestamp":1787295600000,"preClose":1.39,"halted":0,"volume":150346789,"delay":0,"changeRate":-0.0216,"floatShares":13822000000,"shares":13829000000,"eps":-0.0011,"marketStatus":"已收盘","change":-0.03,"latestTime":"08-21 15:00:00","open":1.38,"high":1.39,"low":1.35,"amount":204000000,"amplitude":0.0288,"askPrice":1.36,"askSize":32403,"bidPrice":1.35,"bidSize":166560,"shortable":0,"etf":0,"ttmEps":-0.0011,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":5,"adr":0,"adjPreClose":1.39,"symbolType":"stock","openAndCloseTimeList":[[1787275800000,1787283000000],[1787288400000,1787295600000]],"highLimit":1.53,"lowLimit":1.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":13828896690,"isCdr":false,"pbRate":2.59,"roa":"--","roe":"--","epsLYR":0.0007,"committee":0.129705,"marketValue":18807000000,"turnoverRate":0.0109,"status":1,"floatMarketCap":18798000000},"requestUrl":"/m/hq/s/600518","defaultTab":"news","newsList":[{"id":"2657868148","title":"康美药业:已聘请国内头部券商协助开展市值管理相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2657868148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657868148?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786009018,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业08月06日在投资者关系平台上答复投资者关心的问题。必须立即采取市值管理措施!公司目前生产经营正常,股票价格受宏观经济形势、市场行情等多种因素影响,敬请广大投资者注意二级市场交易风险。现阶段公司已建立股价动态监测机制,已聘请国内头部券商协助开展市值管理相关工作,维护公司长期稳定发展及全体股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","600518","BK0188","BK0077","BK0028","BK0146","BK0239","BK0187","BK0196","BK0097","BK0096","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681483","title":"康美药业:抵债股票由管理人进行公开处置","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657681483?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008998,"startTime":"0","endTime":"0","summary":"根据《重整计划》,提存的偿债资金、股票或信托受益权自重整计划执行完毕之日起满三年,因债权人自身原因仍不领取的,视为放弃受领清偿款项的权利;已提存的偿债资金将用于补充康美药业流动资金;抵债股票由管理人进行公开处置,处置变现价款在支付必要的处置税费后用于补充上市公司经营性流动资金;信托受益权归属于公司,收益扣除信托费用后用于补充上市公司流动资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600518","BK0012","BK0239","BK0028","BK0175","BK0146","BK0196","BK0097","BK0096","BK0187","BK0183","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681430","title":"康美药业:董事及高级管理人员2026年度薪酬由基本薪酬和绩效奖金组成","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657681430?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008998,"startTime":"0","endTime":"0","summary":"公司已建立《董事及高级管理人员薪酬管理制度》,并制定董事、高级管理人员2026年度薪酬方案。在公司担任除董事之外的其他职务并且参与日常公司经营管理的非独立董事及公司高级管理人员2026年度薪酬由基本薪酬和绩效奖金组成,其中绩效奖金占比原则上不低于基本薪酬与绩效奖金总额的50%,与公司年度和任期的经营业绩、绩效考评结果挂钩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600518","BK0175","BK0183","BK0187","BK0012","BK0096","BK0188","BK0097","BK0077","BK0239","BK0146","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681176","title":"康美药业:公司目前生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657681176?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008997,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业08月06日在投资者关系平台上答复投资者关心的问题。公司目前生产经营正常,股票价格受宏观经济形势、市场行情等多种因素影响,敬请广大投资者注意二级市场交易风险。公司持续关注股价走势,不断完善公司治理、提升经营质量,高度重视投资者关系管理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600518","BK0175","BK0239","BK0196","BK0028","BK0097","BK0187","BK0183","BK0012","BK0077","BK0188","BK0146","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657121681","title":"康美药业:已建立股价动态监测机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2657121681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657121681?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008985,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业08月06日在投资者关系平台上答复投资者关心的问题。公司既无回购也无增持,投资者保护措施形同虚设。请制定明确的股东回报规划及实施时间表。现阶段公司已建立股价动态监测机制,已聘请国内头部券商协助开展市值管理相关工作,维护公司长期稳定发展及全体股东利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600518","BK0012","BK0097","BK0187","BK0196","BK0028","BK0183","BK0239","BK0175","BK0188","BK0146","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657144681","title":"康美药业:率先进入更高端的中药饮片市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2657144681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657144681?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008974,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业08月06日在投资者关系平台上答复投资者关心的问题。关于中药饮片集采,公司主动将主战场锚定选货赛道,率先进入更高端的中药饮片市场。近期,新一轮全国中药饮片联盟(第二轮)集中采购结果正式落地,公司中选41个选货、25个统货,选货品种占比远超同行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0096","BK0097","BK0239","BK0012","600518","BK0188","BK0196","BK0077","BK0175","BK0183","BK0187","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657814356","title":"康美药业:中药配方颗粒、趁鲜加工已纳入统一追溯体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2657814356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657814356?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008972,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业08月06日在投资者关系平台上答复投资者关心的问题。智慧药房药事服务追溯系统是否与生产端追溯码全链路打通,患者扫码能否查看全流程信息?公司的中药配方颗粒、趁鲜加工溯源系统建设是参考国标进行规划和建设,目前已纳入统一追溯体系。公司将积极参与饮片溯源相关标准的起草工作,密切跟踪国家政策,不断完善公司饮片和药事服务的追溯体系建设。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600518","BK0183","BK0187","BK0097","BK0077","BK0175","BK0146","BK0012","BK0188","BK0239","BK0028","BK0096","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657814726","title":"康美药业:公司控股股东为广东神农氏企业管理合伙企业(有限合伙)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657814726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657814726?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008971,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业(600518)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问:股东支持措施广药集团作为控股股东,对公司发展提供了哪些支持?请问在战略规划、资源配置、管理提升等方面有哪些具体举措?请详细说明控股股东支持公司高质量发展的行动计划和预期效果,以体现股东责任担当。康美药业回复:尊敬的投资者您好,公司控股股东为广东神农氏企业管理合伙企业(有限合伙),感谢您对公司的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0012","BK0175","BK0188","BK0077","BK0239","BK0187","600518","BK0183","BK0097","BK0146","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681122","title":"康美药业:2025年现金净流入2.23亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681122","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657681122?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008971,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业08月06日在投资者关系平台上答复投资者关心的问题。2025年,公司现金净流入2.23亿元,较上年同期净流出1.13亿元实现明显逆转;其中经营现金净流入1.11亿元,与上年同期净流出4.28亿元相比改善明显,现金流与经营现金流实现“双流为正”,公司自身“造血”功能逐步恢复。公司将持续强化现金流管理,提升资金使用效率,确保财务安全稳健。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600518","BK0188","BK0012","BK0175","BK0096","BK0077","BK0028","BK0183","BK0146","BK0097","BK0187","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681641","title":"康美药业:公司现有溯源平台采用的是企业自定义编码规则","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681641","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657681641?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:33","pubTimestamp":1786008791,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业08月06日在投资者关系平台上答复投资者关心的问题。目前公司已基本完成与医保编码关联映射的技术准备工作,将会在全国医保信息平台正式发布后积极开展对接和调试,感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0028","BK0096","BK0183","600518","BK0077","BK0187","BK0188","BK0239","BK0097","BK0146","BK0196","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654314057","title":"每周股票复盘:康美药业(600518)获139,643.48万元赔偿一审判决","url":"https://stock-news.laohu8.com/highlight/detail?id=2654314057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654314057?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:16","pubTimestamp":1785003373,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,康美药业报收于1.33元,较上周的1.35元下跌1.48%。本周,康美药业7月20日盘中最高价报1.38元。康美药业当前最新总市值183.92亿元,在中药板块市值排名13/66,在两市A股市值排名994/5200。本周关注点公司公告汇总:康美药业作为原告获一审判决,马兴田等被判赔偿139,643.48万元。案件一:广州中院判令马兴田、许冬瑾向公司赔偿139,643.48万元,邱锡伟在14,171.17万元范围内承担补充清偿责任;案件二:正中珠江在14,069.21万元范围内对前述债务承担补充清偿责任。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0012","BK0183","BK0146","BK0196","BK0077","BK0187","BK0188","BK0097","600518","BK0239","BK0028","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653203497","title":"康美药业新注册《康美药业中药药事服务代煎代配处方服务全过程信息追溯平台1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2653203497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653203497?lang=zh_cn&edition=full","pubTime":"2026-07-24 02:23","pubTimestamp":1784830992,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康美药业(600518)新注册了2个项目的软件著作权,包括《康美药业中药药事服务代煎代配处方服务全过程信息追溯平台1.0》、《康美药业中药全产业链溯源平台1.0》等。今年以来康美药业新注册软件著作权2个。结合公司2025年年报财务数据,2025年公司在研发方面投入了4533.04万元,同比减11.91%。通过天眼查大数据分析,康美药业股份有限公司共对外投资了61家企业,参与招投标项目974次;财产线索方面有商标信息2982条,专利信息576条,著作权信息157条;此外企业还拥有行政许可124个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400001609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","BK0077","BK0188","BK0146","BK0183","BK0097","BK0175","BK0096","BK0196","600518","BK0239","BK0187","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653094372","title":"赵建2026年二季度表现,国投瑞银上证科创板人工智能指数发起式A基金季度涨幅40.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653094372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653094372?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:43","pubTimestamp":1784648619,"startTime":"0","endTime":"0","summary":"证券之星消息,截止2026年二季度末,基金经理赵建旗下共管理16只基金,本季度表现最佳的为国投瑞银上证科创板人工智能指数发起式A,季度净值涨40.24%。持有期间的估算收益率为93.31%,持有期间德科立在2024年到2025年的年报营业总收入增幅达10.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0979878070.USD","BK0188","BK0096","LU0501845795.SGD","LU1102505929.USD","LU1328277881.USD","LU0192582467.USD","LU0359201612.USD","LU0314109678.HKD","LU1242518857.USD","LU0572940350.SGD","LU1721428347.USD","LU0231483743.USD","LU1997245094.SGD","EVS.SI","LU0417516902.SGD","LU2097828474.EUR","LU0823414551.USD","LU0651947912.USD","LU1997245177.USD","LU2097828714.EUR","LU2424517915.HKD","LU0029875118.USD","LU0880133367.SGD","LU2153592121.USD","LU0593848301.USD","LU0823413587.USD","LU0326948709.USD","LU1152091168.USD","LU0823414478.USD","LU2506952253.HKD","BK0183","LU0561508036.HKD","LU1794554557.SGD","BK0077","LU2506952410.USD","LU1960683339.HKD","LU2476274308.USD","LU0516422952.EUR","SGXZ49509284.SGD","LU0228659784.USD","600518","LU2298064838.USD","LU0143863784.USD","LU1769817179.HKD","LU0164872284.USD","LU0405327494.USD","LU2476274720.SGD","LU0898667661.SGD","LU0509642566.USD","LU1974910355.USD","SG9999002463.SGD","LU0320764755.SGD","LU0039217434.USD","SGXZ81163826.USD","688205","LU2348774022.SGD","LU0312595415.SGD","LU1807302812.USD","LU2294711713.HKD","LU1255011170.USD","IE00BZ199S13.USD","LU2357125470.USD","IE0003795394.USD","LU0132412106.USD","LU0254981946.USD","LU2449936058.SGD","LU1146622755.USD","LU2506951792.HKD","LU0048580855.USD","LU0611395673.USD","LU0405327148.USD","BK0239","LU0106259558.USD","LU1993786604.SGD","LU2275660780.HKD","LU2289578879.USD","LU0106252389.USD","LU2328871848.SGD","LU2360107325.USD","LU1048588211.SGD","LU2477742899.HKD","LU0516422440.USD","LU1048596156.SGD","LU1051769294.HKD","LU2394011477.USD","LU2152927971.USD","HK0000181138.USD","LU0828237940.HKD","LU2495084118.USD","HK0000151867.HKD","SG9999001846.SGD","IE00BD6J9T35.USD","LU1770034418.SGD","SG9999001903.USD","IE00B3M56506.USD","LU0326950275.SGD","LU1051768304.USD","LU0594300419.USD","LU0328353924.USD","300750","LU1303224171.USD","LU2153591404.USD","LU0516423091.SGD","LU2580892789.USD","LU2580892862.HKD","LU2298321311.HKD","BK0175","LU0181495838.USD","LU0828238088.HKD","LU0823426480.USD","LU1064131003.USD","LU0051755006.USD","BK0097","LU0165289439.USD","LU0072462343.USD","LU1868838027.USD","LU1978683503.SGD","LU0469268626.HKD","LU0823413660.USD","LU1880383440.USD","LU0831103253.SGD","LU1720050803.USD","IE00B29SXG58.USD","SG9999003461.SGD","LU0594300179.USD","LU1868837565.USD","LU2242644610.SGD","LU0210527791.USD","LU1023057109.AUD","BK0187","LU2238339852.HKD","LU1769817096.USD","LU2778985437.USD","LU1831875114.USD","LU1242518931.SGD","IE0003851619.USD","LU0672654166.SGD","IE0032431581.USD","LU1781817850.SGD","LU0047713382.USD","BK0028","HK0000181112.HKD","LU1008478684.HKD","IE00B543WZ88.USD","LU0531971595.HKD","LU1934453819.USD","LU1939255532.USD","LU2125910500.SGD","LU2023250504.SGD","LU0054450605.USD","LU0244354667.USD","LU0724618433.USD","LU1861214812.USD","BK0012","LU0327786744.USD","LU2249611893.SGD","CXSE","LU0117844026.USD","LU0650527681.SGD","LU2294711473.HKD","LU0531970944.HKD","LU1861219969.SGD","LU0011963245.USD","IE00B8L5B284.USD","LU0359201885.HKD","LU0516422366.SGD","LU0049853897.USD","LU0067412154.USD","SG9999002828.SGD","LU1813983027.USD","LU0456827905.SGD","LU2045819591.USD","LU2092937221.SGD","LU0140636845.USD","LU0348825331.USD","LU0572944931.SGD","LU1515016050.SGD","LU0605514214.HKD","LU0823426308.USD","LU0214875030.USD","LU1808992512.USD","LU0607220059.USD","LU0784639295.USD","LU0345770993.USD","LU2360108059.USD","LU1152091754.HKD","LU0107464264.USD","LU0043850808.USD","BK0146","LU1251922891.USD","LU0516423174.USD","LU0823437842.USD","IE00B5MMRT66.SGD","LU1188198961.HKD","LU0651946864.USD","LU1961090484.USD","LU0370786039.SGD","LU0463099449.HKD","LU1039395188.USD","LU1880383366.USD","LU0449509016.USD","LU0543330483.HKD","LU0128522157.USD","LU0235996351.USD","LU0251143458.SGD","LU0348827113.USD","LU3063872942.SGD","LU2097828631.EUR","LU2125910849.SGD","LU2041044095.USD","LU1580142542.USD","LU1997244956.HKD","LU2039709279.SGD","IE00BPRC5H50.USD","LU0359202008.SGD","LU0143863198.USD","LU2506952337.HKD","LU0345770308.USD","SG9999000327.SGD","LU0828237510.HKD","LU1969619763.USD","LU1655091459.SGD","LU1979443071.USD","LU0072913022.USD","LU0266013472.USD","LU0048388663.USD","LU0164865239.USD","SG9999000459.SGD","LU0106959298.USD","LU0449515922.USD","LU0210526637.USD","LU0149534421.HKD","LU0259732245.USD","LU2348773727.SGD","LU1719994722.HKD","LIT","LU0048575426.USD","LU0261950470.USD","LU0264606111.USD","LU0269904917.USD","LU0302445910.USD","LU0505663152.USD","BK0214","LU0188438112.USD","LU1102505762.USD","LU1820825898.SGD","BK0196","03750","BK0224","LU0124384867.USD","LU1064130708.USD","LU1655091616.SGD","LU0455707207.USD","LU1917777945.USD","LU0572939691.SGD","LU2148510915.USD","LU2399975544.HKD","LU2097828805.USD","LU0821914370.USD","SG9999001689.USD","LU0871576103.HKD","LU2106854487.HKD","LU0348805143.USD","LU0502904849.HKD","IE00B8HQ1Z84.USD","LU2097828557.USD","LU2298322129.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653243328","title":"康美药业获得实用新型专利授权:“一种卸液装置及药渣处理设备”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653243328","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653243328?lang=zh_cn&edition=full","pubTime":"2026-07-21 03:20","pubTimestamp":1784575249,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示康美药业新获得一项实用新型专利授权,专利名为“一种卸液装置及药渣处理设备”,专利申请号为CN202521607701.1,授权日为2026年7月21日。今年以来康美药业新获得专利授权17个,较去年同期减少了22.73%。通过天眼查大数据分析,康美药业股份有限公司共对外投资了61家企业,参与招投标项目974次;财产线索方面有商标信息2982条,专利信息576条,著作权信息157条;此外企业还拥有行政许可124个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100003263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0146","BK0183","BK0097","BK0175","BK0096","BK0196","600518","BK0239","BK0187","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648660593","title":"康美药业获得实用新型专利授权:“一种接料辅助装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2648660593","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648660593?lang=zh_cn&edition=full","pubTime":"2026-07-04 03:40","pubTimestamp":1783107648,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示康美药业新获得一项实用新型专利授权,专利名为“一种接料辅助装置”,专利申请号为CN202521673909.3,授权日为2026年6月19日。今年以来康美药业新获得专利授权12个,较去年同期减少了40%。通过天眼查大数据分析,康美药业股份有限公司共对外投资了60家企业,参与招投标项目971次;财产线索方面有商标信息2982条,专利信息572条,著作权信息157条;此外企业还拥有行政许可124个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070400001843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600518","BK0012","BK0097","BK0187","BK0196","BK0028","BK0183","BK0239","BK0175","BK0188","BK0146","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343193","title":"股市必读:康美药业(600518)6月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647343193?lang=zh_cn&edition=full","pubTime":"2026-06-29 03:16","pubTimestamp":1782674172,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,康美药业报收于1.21元,下跌3.97%,换手率1.7%,成交量234.74万手,成交额2.88亿元。董秘最新回复投资者: 最新的股东户数是多少?投资者: 康美药业:公司股价今天又创出新低1.31元,公司没有增持、没有回购维持股价的迹象。投资者: 康美药业:2026年5月21日我提问公司有面值退市风险吗?当时股价1.51元,公司答复“目前不存在触及退市风险警示的情形”。仅过了18个交易日康美药业股价跌至1.33元,离面值退市更进一步。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900001016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0096","BK0077","600518","BK0012","BK0175","BK0097","BK0028","BK0146","BK0183","BK0188","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353302","title":"康美药业:公司生产经营正常,目前没有触及退市风险警示情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646353302?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:18","pubTimestamp":1782465522,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业(600518)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:公司股票票额今天1.38元每股,离退市低于或等于1元已经不远了,公司打算什么时候退市?很快吗?康美药业回复:尊敬的投资者您好,感谢您对公司的关注。公司生产经营正常,目前没有触及退市风险警示情形。股票价格受宏观经济形势、市场行情等多种因素影响,敬请广大投资者注意二级市场交易风险。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0096","BK0097","BK0239","BK0012","600518","BK0188","BK0196","BK0077","BK0175","BK0183","BK0187","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646535933","title":"康美药业:截至2026年3月31日,公司股东总户数为300,298户","url":"https://stock-news.laohu8.com/highlight/detail?id=2646535933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646535933?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:18","pubTimestamp":1782465520,"startTime":"0","endTime":"0","summary":"证券之星消息,康美药业(600518)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:现在最新的股东户数是多少?康美药业回复:尊敬的投资者您好,公司按照上市公司信息披露相关法律法规在定期报告中披露报告期末股东户数。根据公司2026年第一季度报告,截至2026年3月31日,公司股东总户数为300,298户,感谢您对公司的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0096","BK0097","BK0239","BK0012","600518","BK0188","BK0196","BK0077","BK0175","BK0183","BK0187","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639631643","title":"康美药业:中药饮片仍是公司的核心主业和战略基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2639631643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639631643?lang=zh_cn&edition=full","pubTime":"2026-05-29 10:32","pubTimestamp":1780021938,"startTime":"0","endTime":"0","summary":"公司本次经营范围变更系根据市场监管部门最新规范进行的表述调整,并未取消中药饮片及中药配方颗粒的生产。公司主营业务未发生变更,中药饮片仍是公司的核心主业和战略基石,公司下属各饮片生产基地均正常运营。具体修订情况详见公司于2026年5月27日披露的《康美药业关于变更公司经营范围暨修订<公司章程>的公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900014061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0028","BK0096","BK0175","BK0196","BK0188","BK0187","BK0097","BK0146","BK0183","BK0077","600518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636061628","title":"每周股票复盘:康美药业(600518)召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2636061628","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636061628?lang=zh_cn&edition=full","pubTime":"2026-05-17 01:59","pubTimestamp":1778954346,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:康美药业于2026年5月14日召开2025年年度股东会,审议通过董事会工作报告、年度报告、利润分配预案等多项议案。公司公告汇总:康美药业将于2026年5月22日召开2025年度暨2026年第一季度业绩说明会,管理层将与投资者在线交流。公司公告汇总康美药业于2026年5月14日召开2025年年度股东会,会议由董事长赖志坚主持,采用现场与网络投票结合方式召开。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0096","BK0097","BK0239","BK0012","600518","BK0188","BK0196","BK0077","BK0175","BK0183","BK0187","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787305728417,"stockEarnings":[{"period":"1week","weight":-0.0414},{"period":"1month","weight":0.0373},{"period":"3month","weight":-0.109},{"period":"6month","weight":-0.2646},{"period":"1year","weight":-0.3349},{"period":"ytd","weight":-0.2723}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0102},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0365},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康美药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"300298人(较上一季度增加0.79%)","perCapita":"46028股","listingDate":"2001-03-19","address":"广东省揭阳市普宁市揭神路东侧","registeredCapital":"1382889万元","survey":" 康美药业股份有限公司的主营业务是以中药饮片生产、销售为核心,实施中医药全产业链一体化。公司的主要产品是保宁半夏颗粒、乐脉丸、心脑欣丸、清热解毒的抗感解毒颗粒、解毒利咽的板蓝根颗粒、复方板蓝根颗粒,解表散热的小柴胡颗粒、清肝明目的夏桑菊颗粒、滋阴补肾的六味地黄丸、阿咖酚散、新开河超微参粉胶囊、康美菊皇口服液浓缩液、康美怡泰口服液浓缩液、菊皇茶、固体饮料、人参片、红参浸膏。公司是国家技术创新示范企业、国家知识产权示范企业,也是国内唯一的中药饮片智能制造试点示范企业。","listedPrice":12.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康美药业(600518)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康美药业(600518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康美药业,600518,康美药业股票,康美药业股票老虎,康美药业股票老虎国际,康美药业行情,康美药业股票行情,康美药业股价,康美药业股市,康美药业股票价格,康美药业股票交易,康美药业股票购买,康美药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康美药业(600518)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康美药业(600518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}